Aids-related malignancies (original) (raw)

• Sondel, P. M., Rakhmilevich, A. L., de Jong, J. L. O. & Hank, J. A. in The Molecular Basis of Cancer (eds Mendelsohn, J., Howley, P. M., Israel, M. A. & Liotta, L. A.) 535–571 (W. B. Saunders Company, Philadelpia, 2001).
  Google Scholar
• Burnet, F. M. Immunologic surveillance in neoplasia. Transplant. Rev. 7, 3 (1971).
  CAS PubMed Google Scholar
• Gross, L. Intradermal immunization of C3H mice against sarcoma that originated in an animal of the same line. Cancer Res. 3, 326 (1943).
  Google Scholar
• Klein, G. & Klein, E. Genetic studies of the relationship of tumour-host cells. Nature 178, 1389 (1956).
  Article CAS PubMed Google Scholar
• Penn, I. Tumors arising in organ transplant recipients. Adv. Cancer Res. 28, 31–61 (1978).
  Article CAS PubMed Google Scholar
• Frisch, M., Biggar, R. J., Engels, E. A. & Goedert, J. J. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285, 1736–1745 (2001).Analysis of the incidence of cancer among 302,834 adults with HIV/AIDS from 11 geographically diverse areas in the United States.
  Article CAS PubMed Google Scholar
• Stewart, T., Tsai, S. C., Grayson, H., Henderson, R. & Opelz, G. Incidence of de novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 346, 796–798 (1995).
  Article CAS PubMed Google Scholar
• Gallagher, B., Wang, Z., Schymura, M. J., Kahn, A. & Fordyce, E. J. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am. J. Epidemiol. 154, 544–556 (2001).Population-based registry linkage analysis evaluating cancer risk in HIV/AIDS individuals in one of the areas of the United States most heavily afflicted by this disease.
  Article CAS PubMed Google Scholar
• Rickinson, A. B. et al. T cell recognition of Epstein–Barr virus associated lymphomas. Cancer Surv. 13, 53–80 (1992).
  CAS PubMed Google Scholar
• Parkin, D. M., Wabinga, H., Nambooze, S. & Wabwire-Mangen, F. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 13, 2563–2570 (1999).
  Article CAS PubMed Google Scholar
• Kaposi, M. Idiopathisches multiplespigmentsarcom der haut. Arch. Dermatologie Syphillis 4, 265–273 (1872).
  Google Scholar
• Franceschi, S. & Serraino, D. Kaposi's sarcoma and KSHV. Lancet 346, 1360–1361 (1995).
  CAS PubMed Google Scholar
• Rothman, S. in Symposium on Kaposi's sarcoma (eds Ackerman, L. V. & Murray, J. F.) (Karger, Basel, 1962).
  Google Scholar
• d'Oliveira, J. J. & Torres, F. O. Kaposi's sarcoma in the Bantu of Mozambique. Cancer 30, 553–561 (1972).
  Article CAS PubMed Google Scholar
• Olweny, C. L. Etiology of endemic Kaposi's sarcoma. IARC Sci. Publ. 63, 543–548 (1984).
  Google Scholar
• Oettle, A. G. in Symposium on Kaposi's sarcoma (eds Ackerman, L. V. & Murray, J. F.) (Karger, Basel, 1962).
  Google Scholar
• Harwood, A. R. et al. Kaposi's sarcoma in recipients of renal transplants. Am. J. Med. 67, 759–765 (1979).
  Article CAS PubMed Google Scholar
• Penn, I. Kaposi's sarcoma in transplant recipients. Transplantation 64, 669–673 (1997).
  Article CAS PubMed Google Scholar
• Qunibi, W. et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am. J. Med. 84, 225–232 (1988).
  Article CAS PubMed Google Scholar
• Franceschi, S. & Geddes, M. Epidemiology of clasic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori 81, 308–314 (1995).
  Article CAS PubMed Google Scholar
• Beral, V., Peterman, T. A., Berkelman, R. L. & Jaffe, H. W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335, 123–128 (1990).One of the first studies to indicate that an infectious agent other than HIV is involved in the pathogenesis of AIDS/KS.
  Article CAS PubMed Google Scholar
• Rabkin, C. S. & Yellin, F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J. Natl Cancer Inst. 86, 1711–1716 (1994).Large study that examines the risk of cancer in gay men who are at risk of HIV/AIDS before the use of antiretroviral treatment.
  Article CAS PubMed Google Scholar
• Rabkin, C. S., Goedert, J. J., Biggar, R. J., Yellin, F. & Blattner, W. A. Kaposi's sarcoma in three HIV-1-infected cohorts. J. Acquir. Immune Defic. Syndr. 3 (Suppl. 1), S38–S43 (1990).
  PubMed Google Scholar
• Chang, Y. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869 (1994).One of the most successful and important applications of Lisitsyn's representational difference analysis (RDA): the identification of KSHV sequences in AIDS/KS.
  Article CAS PubMed Google Scholar
• Kedes, D. H. et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med. 2, 918–924 (1996).One of the first seroepidemiological studies that confirmed the link between KSHV and AIDS/KS.
  Article CAS PubMed Google Scholar
• Gao, S. J. et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Med. 2, 925–928 (1996).
  Article CAS PubMed Google Scholar
• Liotta, L. A. & Kohn, E. C. The microenvironment of the tumour-host interface. Nature 411, 375–379 (2001).
  Article CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammatory cells and cancer: think different! J. Exp. Med. 193, F23–F26 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Bissell, M. J. & Radisky, D. Putting tumours into context. Nature Rev. Cancer 1, 46–54 (2001).
  Article CAS Google Scholar
• Berd, D. & Prehn, R. T. Peritoneal macrophage response to leukemia L1210 in syngeneic mice. J. Natl Cancer Inst. 58, 1729–1734 (1977).
  Article CAS PubMed Google Scholar
• Ensoli, B., Salahuddin, S. Z. & Gallo, R. C. AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis. Cancer Cells 1, 93–96 (1989).
  CAS PubMed Google Scholar
• Gallo, R. C. The enigmas of Kaposi's sarcoma. Science 282, 1837–1839 (1998).
  Article CAS PubMed Google Scholar
• Rabkin, C. S. et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N. Engl. J. Med. 336, 988–993 (1997).
  Article CAS PubMed Google Scholar
• Gill, P. S. et al. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc. Natl Acad. Sci. USA 95, 8257–8261 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Roth, W. K., Brandstetter, H. & Sturzl, M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 6, 895–913 (1992).
  Article CAS PubMed Google Scholar
• Veikkola, T. et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20, 1223–1231 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Jussila, L. et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58, 1599–1604 (1998).
  CAS PubMed Google Scholar
• Dupin, N. et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl Acad. Sci. USA 96, 4546–4551 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Weninger, W. et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79, 243–251 (1999).
  CAS PubMed Google Scholar
• Salahuddin, S. Z. et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 242, 430–433 (1988).
  Article CAS PubMed Google Scholar
• Miles, S. A. et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl Acad. Sci. USA 87, 4068–4072 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Ensoli, B. et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243, 223–226 (1989).
  Article CAS PubMed Google Scholar
• Fiorelli, V. et al. γ-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood 91, 956–967 (1998).
  CAS PubMed Google Scholar
• Ensoli, B., Barillari, G. & Gallo, R. C. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol. Rev. 127, 147–155 (1992).
  Article CAS PubMed Google Scholar
• Albini, A., Barillari, G., Benelli, R., Gallo, R. C. & Ensoli, B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl Acad. Sci. USA 92, 4838–4842 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Vogel, J., Hinrichs, S. H., Reynolds, R. K., Luciw, P. A. & Jay, G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335, 606–611 (1988).
  Article CAS PubMed Google Scholar
• Proceedings of the IARC Working Group on the evaluation of carcinogenic risks to humans. Epstein–Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus-8. Lyon, France, 17–24 June 1997. IARC Monogr Eval. Carcinog. Risks Hum. 70, 1–492 (1997).
• Whitby, D. et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346, 799–802 (1995).
  Article CAS PubMed Google Scholar
• Moore, P. S. et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 10, 175–180 (1996).
  Article CAS PubMed Google Scholar
• Chatlynne, L. G. & Ablashi, D. V. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin. Cancer Biol. 9, 175–185 (1999).
  Article CAS PubMed Google Scholar
• Staskus, K. A. et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71, 715–719 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Sturzl, M. et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int. J. Cancer 72, 68–71 (1997).
  Article CAS PubMed Google Scholar
• Radkov, S. A., Kellam, P. & Boshoff, C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells. Nature Med. 6, 1121–1127 (2000).First study to show that KSHV, like other oncogenic viruses, encodes for a latent transforming protein that targets the retinoblastoma tumour-suppressor pathway.
  Article CAS PubMed Google Scholar
• An, J., Lichtenstein, A. K., Brent, G. & Rettig, M. B. The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood 99, 649–654 (2002).
  Article CAS PubMed Google Scholar
• Judde, J. G. et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J. Natl Cancer Inst. 92, 729–736 (2000).
  Article CAS PubMed Google Scholar
• Ablashi, D. et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br. J. Cancer 81, 893–897 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Davidovici, B. et al. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J. Natl Cancer Inst. 93, 194–202 (2001).Definitive sero-epidemiological study showing that KSHV is transmitted among family members in a Western population.
  Article CAS PubMed Google Scholar
• Mayama, S. et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int. J. Cancer 77, 817–820 (1998).
  Article CAS PubMed Google Scholar
• Sitas, F. et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. N. Engl. J. Med. 340, 1863–1871 (1999).
  Article CAS PubMed Google Scholar
• Koelle, D. M. et al. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J. Infect. Dis. 176, 94–102 (1997).
  Article CAS PubMed Google Scholar
• Pauk, J. et al. Mucosal shedding of human herpesvirus 8 in men. N. Engl. J. Med. 343, 1369–1377 (2000).
  Article CAS PubMed Google Scholar
• Olsen, S. J., Chang, Y., Moore, P. S., Biggar, R. J. & Melbye, M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 12, 1921–1925 (1998).
  Article CAS PubMed Google Scholar
• Gessain, A. et al. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int. J. Cancer 81, 189–192 (1999).
  Article CAS PubMed Google Scholar
• Plancoulaine, S. et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356, 1062–1065 (2000).
  Article CAS PubMed Google Scholar
• Ariyoshi, K. et al. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J. Hum. Virol. 1, 193–199 (1998).
  CAS PubMed Google Scholar
• Goudsmit, J. et al. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984–1997): analysis of seroconversions to ORF65 and ORF73. Proc. Natl Acad. Sci. USA 97, 4838–4843 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ziegler, J. L. et al. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS 11, 1619–1626 (1997).
  Article CAS PubMed Google Scholar
• Lunardi-Iskandar, Y. et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375, 64–68 (1995).
  Article CAS PubMed Google Scholar
• Thorley-Lawson, D. A. Epstein–Barr virus: exploiting the immune system. Nature Rev. Immunol. 1, 75–82 (2001).Important review arguing that Epstein–Barr virus exploits the normal maturation/differentiation of B lymphocytes for its own replication and survival.
  Article CAS Google Scholar
• Klein, G. Epstein–Barr virus strategy in normal and neoplastic B cells. Cell 77, 791–793 (1994).
  Article CAS PubMed Google Scholar
• Babcock, G. J. & Thorley-Lawson, D. A. Tonsillar memory B cells, latently infected with Epstein–Barr virus, express the restricted pattern of latent genes previously found only in Epstein–Barr virus-associated tumors. Proc. Natl Acad. Sci. USA 97, 12250–12255 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kuppers, R., Klein, U., Hansmann, M. L. & Rajewsky, K. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341, 1520–1529 (1999).
  Article CAS PubMed Google Scholar
• Gaidano, G. & Della-Favera, R. in The Molecular Basis of Cancer (eds Mendelsohn, J., Howley,P. M., Israel, M. A. & Liotta, L. A.) 189–237 (W. B. Saunders Company, Philadelphia, 2001).
  Google Scholar
• Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. & Knowles, D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186–1191 (1995).
  Article CAS PubMed Google Scholar
• Soulier, J. et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276–1280 (1995).
  Article CAS PubMed Google Scholar
• Shirai, A., Cosentino, M., Leitman-Klinman, S. F. & Klinman, D. M. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J. Clin. Invest. 89, 561–566 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Grulich, A. E. et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 14, 133–140 (2000).
  Article CAS PubMed Google Scholar
• Lane, H. C. et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309, 453–458 (1983).
  Article CAS PubMed Google Scholar
• Cunto-Amesty, G., Przybylski, G., Honczarenko, M., Monroe, J. G. & Silberstein, L. E. Evidence that immunoglobulin specificities of AIDS-related lymphoma are not directed to HIV-related antigens. Blood 95, 1393–1399 (2000).
  Article CAS PubMed Google Scholar
• Shope, R. E. Infectious papillomatosis. J. Exp. Med. 58, 607–624 (1933).
  Article CAS PubMed PubMed Central Google Scholar
• Rous, P. & Kidd, J. G. The carcinogenic effect of a virus upon tarred skin. Science 83, 468 (1936).
  Article CAS PubMed Google Scholar
• Zur Hausen, H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr. Top. Microbiol. Immunol. 78, 1 (1977).
  CAS PubMed Google Scholar
• Durst, M., Gissmann, L., Ikenberg, H. & zurHausen, H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA 80, 3812–3815 (1983).The identification of HPV sequences in cervical cancer and the first study to identify a human DNA tumour virus using only molecular techniques.
  Article CAS PubMed PubMed Central Google Scholar
• Lowry, W. S., Clark, D. A. & Hannemann, J. H. Skin cancer and immunosuppression. Lancet 1, 1290–1291 (1972).
  Article CAS PubMed Google Scholar
• Matas, A. J., Simmons, R. L. & Najarian, J. S. Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients. Lancet 1, 1277–1279 (1975).
  Article CAS PubMed Google Scholar
• Frazer, I. H., Medley, G., Crapper, R. M., Brown, T. C. & Mackay, I. R. Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet 2, 657–660 (1986).
  Article CAS PubMed Google Scholar
• Frisch, M., Biggar, R. J. & Goedert, J. J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Natl Cancer Inst. 92, 1500–1510 (2000).
  Article CAS PubMed Google Scholar
• Ateenyi-Agaba, C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 345, 695–696 (1995).
  Article CAS PubMed Google Scholar
• Gomousa-Michael, M., Gialama, E., Gomousas, N. & Gialama, G. Genital human papillomavirus infection and associated penile intraepithelial neoplasia in males infected with the human immunodeficiency virus. Acta Cytol. 44, 305–309 (2000).
  Article CAS PubMed Google Scholar
• Trottier, A. M. et al. Human immunodeficiency virus infection is a major risk factor for detection of human papillomavirus DNA in esophageal brushings. Clin. Infect. Dis. 24, 565–569 (1997).
  Article CAS PubMed Google Scholar
• Palefsky, J. M., Holly, E. A., Ralston, M. L. & Jay, N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV- negative homosexual men. J. Infect. Dis. 177, 361–367 (1998).
  Article CAS PubMed Google Scholar
• Palefsky, J. M. et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J. Natl Cancer Inst. 91, 226–236 (1999).
  Article CAS PubMed Google Scholar
• Sun, X. W. et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N. Engl. J. Med. 337, 1343–1349 (1997).
  Article CAS PubMed Google Scholar
• Arany, I., Muldrow, M. & Tyring, S. K. Correlation between mRNA levels of IL-6 and TNF-α and progression rate in anal squamous epithelial lesions from HIV-positive men. Anticancer Res. 21, 425–428 (2001).
  CAS PubMed Google Scholar
• McMurray, H. R., Nguyen, D., Westbrook, T. F. & McCance, D. J. Biology of human papillomaviruses. Int. J. Exp. Pathol. 82, 15–33 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J. Natl Cancer Inst. 92, 1823–1830 (2000).Major international study that assesses the role of HAART in the incidence of AIDS-related malignancies.
• Osmond, D. H. et al. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA 287, 221–225 (2002).
  Article PubMed Google Scholar
• Dupin, N. et al. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma. Br. J. Dermatol. 140, 875–881 (1999).
  Article CAS PubMed Google Scholar
• Hoffmann, C. et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15, 2119–2127 (2001).
  Article CAS PubMed Google Scholar
• Besson, C. et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98, 2339–2344 (2001).
  Article CAS PubMed Google Scholar
• Kirk, O. et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98, 3406–3412 (2001).
  Article CAS PubMed Google Scholar
• De Clercq, E. et al. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev. Med. Virol. 11, 381–395 (2001).
  Article CAS PubMed Google Scholar
• Spach, D. H. & Colven, R. Resolution of recalcitrant hand warts in an HIV-infected patient treated with potent antiretroviral therapy. J. Am. Acad. Dermatol. 40, 818–821 (1999).
  Article CAS PubMed Google Scholar
• Ellis, L. M. & Fidler, I. J. in The Molecular Basis of Cancer (eds Mendelsohn, J., Howley, P. M., Israel, M. A. & Liotta, L. A.) 173–189 (W. B. Saunders, Philadelphia, 2001).
  Google Scholar
• Zabawski, E. J. Jr & Cockerell, C. J. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects. J. Am. Acad. Dermatol. 39, 741–745 (1998).
  Article PubMed Google Scholar
• Faye, A., Van Den, A. T., Peuchmaur, M., Mathieu-Boue, A. & Vilmer, E. Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet 352, 1285 (1998).
  Article CAS PubMed Google Scholar
• Corbellino, M. et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98, 3473–3475 (2001).
  Article CAS PubMed Google Scholar
• Karkkainen, M. J., Makinen, T. & Alitalo, K. Lymphatic endothelium: a new frontier of metastasis research. Nature Cell Biol. 4, E2–E5 (2002).
  Article CAS PubMed Google Scholar
• Du, M. Q. et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgMλ) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97, 2130–2136 (2001).
  Article CAS PubMed Google Scholar
• Munger, K. The molecular biology of cervical cancer. J. Cell Biochem. 23 (Suppl.), 55–60 (1995).
  Article CAS Google Scholar
• Dyson, N., Howley, P. M., Munger, K. & Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934–937 (1989).First paper to show that a human oncogenic virus targets the retinoblastoma pathway.
  Article CAS PubMed Google Scholar
• Gage, J. R., Meyers, C. & Wetterstein, F. O. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J. Virol. 64, 723–730 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Godden-Kent, D. et al. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates CDK6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol. 71, 4193–4198 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Ellis, M. et al. Degradation of p27(Kip) CDK inhibitor triggered by Kaposi's sarcoma virus cyclin–CDK6 complex. EMBO J. 18, 644–653 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Mann, D. J., Child, E. S., Swanton, C., Laman, H. & Jones, N. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J. 18, 654–663 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Swanton, C. et al. Herpes viral cyclin–CDK6 complexes evade inhibition by CDK inhibitor proteins. Nature 390, 184–187 (1997).
  Article CAS PubMed Google Scholar
• Laman, H., Coverley, D., Krude, T., Laskey, R. & Jones, N. Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol. Cell. Biol. 21, 624–635 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Brander, C. et al. Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus. J. Immunol. 165, 2077–2083 (2000).
  Article CAS PubMed Google Scholar
• Wilkinson, J. et al. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. J. Virol. 76, 2634–2640 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, Z. et al. Epstein–Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas. Recent Results Cancer Res. 159, 123–133 (2002).
  Article CAS PubMed Google Scholar
• Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C. & Wong-Staal, F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84–86 (1990).
  Article CAS PubMed Google Scholar
• Ensoli, B. et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371, 674–680 (1994).Classic paper on the interplay between HIV-1 Tat and bFGF to induce angiogenesis in an experimental model.
  Article CAS PubMed Google Scholar
• Tovo, P. A. Highly active antiretroviral therapy inhibits cytokine production in HIV-uninfected subjects. AIDS 14, 743–744 (2000).
  Article CAS PubMed Google Scholar
• Sgadari, C. et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi's sarcoma. Nature Med. 8, 225–232 (2002).Provocative study on the future use of protease inhibitors to interfere with angiogenesis.
  Article CAS PubMed Google Scholar
• Bower, M. et al. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. AIDS 13, 2105–2111 (1999).
  Article CAS PubMed Google Scholar
• Carmeliet, P. Developmental biology: one cell, two fates. Nature 408, 43–45 (2000).
  Article CAS PubMed Google Scholar
• Yamashita, J. et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92–96 (2000).
  Article CAS PubMed Google Scholar
• Makinen, T. et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762–4773 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Witmer, A. N. et al. VEGFR-3 in adult angiogenesis. J. Pathol. 195, 490–497 (2001).
  Article CAS PubMed Google Scholar
• Breiteneder-Geleff, S. et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154, 385–394 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Holzhausen, H. J., Stiller, D. & Sachs, M. [Morphological pathology of classic Kaposi's sarcoma. Ultrastructural studies and reflections on histogenesis]. Zentralbl. Allg. Pathol. 134, 435–447 (1988).
  CAS PubMed Google Scholar
• Akula, S. M., Pramod, N. P., Wang, F. Z. & Chandran, B. Integrin α3β1 (CD 49c/29) is a cellular receptor for Kaposi's sacroma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108, 407–419 (2002).
  Article CAS PubMed Google Scholar
• Rivas, C., Thlick, A. E., Parravicini, C., Moore, P. S. & Chang, Y. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75, 429–438 (2001).
  Article CAS PubMed PubMed Central Google Scholar